Series C startup

Who invested in Elpiscience Biopharmaceuticals

One round we have observed, with the 5 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Pharma

Funding summaryUpdated 26 Oct 2026

$105Mraised across 1 round since 2021, from 1 source

Latest round
Series C, $105MMay 2021
Investors
5
See who backed them

The rounds

  1. May 2021

Everyone who backed them

Tengxun TouziVC firm1round
Hill House CapitalFamily office1round
CDH InvestmentsPrivate equity1round
Cormorant Asset ManagementPrivate equity1round
Lilly Asia VenturesVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Elpiscience Biopharmaceuticals

Who invested in Elpiscience Biopharmaceuticals?

Elpiscience Biopharmaceuticals's investors include Tengxun Touzi, Hill House Capital, CDH Investments, Cormorant Asset Management and Lilly Asia Ventures.

How much has Elpiscience Biopharmaceuticals raised?

Elpiscience Biopharmaceuticals has raised $105M across 1 round since 2021.

When did Elpiscience Biopharmaceuticals last raise?

Elpiscience Biopharmaceuticals's most recent round was a Series C of $105M in May 2021.

What was Elpiscience Biopharmaceuticals's biggest round?

Its most recent round, $105M in May 2021, is also its largest on record.

Who backed Elpiscience Biopharmaceuticals first?

Elpiscience Biopharmaceuticals's first round on record, in May 2021, was backed by Tengxun Touzi, Hill House Capital and CDH Investments and 2 others.

What stage is Elpiscience Biopharmaceuticals at?

Elpiscience Biopharmaceuticals's latest named round is a Series C, in May 2021.

Companies like Elpiscience Biopharmaceuticals

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.